138 related articles for article (PubMed ID: 3322924)
21. Omeprazole.
Maton PN
N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
[No Abstract] [Full Text] [Related]
22. [Cimetidine].
Castro Lde P; Salgado JA
AMB Rev Assoc Med Bras; 1981 Oct; 27(10):301-4. PubMed ID: 7045988
[No Abstract] [Full Text] [Related]
23. [Treatment of peptic ulcer and reflux esophagitis with enzyme inhibitors].
Moriya S; Omura N; Kashiwagi H; Inagaki Y; Aoki T
Nihon Rinsho; 1991 Sep; 49(9):2115-9. PubMed ID: 1835742
[No Abstract] [Full Text] [Related]
24. The clinical safety of omeprazole.
Sölvell L
Scand J Gastroenterol Suppl; 1989; 166():106-10; discussion 111-3. PubMed ID: 2690327
[TBL] [Abstract][Full Text] [Related]
25. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
26. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
27. Criteria for use of omeprazole in adult inpatients and outpatients.
Lajoie C
Clin Pharm; 1992 Feb; 11(2):177-9. PubMed ID: 1551300
[No Abstract] [Full Text] [Related]
28. [Omeprazole and peptic ulcer. Profile of a new active agent].
Müller P; Dammann HG; Simon B
Fortschr Med; 1987 Jan; 105(2):35-8. PubMed ID: 3557254
[No Abstract] [Full Text] [Related]
29. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
30. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
31. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
Lauritsen K; Laursen LS; Madsen JR
Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
[No Abstract] [Full Text] [Related]
32. [Advances in the knowledge of peptic-acid dependent diseases].
Mazure PA; Pigliacampo J
Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
[No Abstract] [Full Text] [Related]
33. The impact of cimetidine on the treatment of acid-peptic disease.
Fleshler B
Prim Care; 1981 Jun; 8(2):195-203. PubMed ID: 7027288
[No Abstract] [Full Text] [Related]
34. Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor.
Tonini M; Vigneri S; Savarino V; Scarpignato C
Dig Liver Dis; 2001 Oct; 33(7):600-6. PubMed ID: 11816552
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal hormones in the pathogenesis of peptic ulcer disease.
Taylor IL
Clin Gastroenterol; 1984 May; 13(2):355-82. PubMed ID: 6146415
[No Abstract] [Full Text] [Related]
36. Is there a need for strong gastric acid inhibition in clinical practice?
Lamers CB
Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
[TBL] [Abstract][Full Text] [Related]
37. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
Lampkin TA; Ouellet D; Hak LJ; Dukes GE
DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
[TBL] [Abstract][Full Text] [Related]
38. Effect of cigarette smoking on gastrointestinal physiology and non-neoplastic digestive disease.
Kikendall JW; Evaul J; Johnson LF
J Clin Gastroenterol; 1984 Feb; 6(1):65-79. PubMed ID: 6366043
[No Abstract] [Full Text] [Related]
39. Omeprazole: a new drug for the treatment of acid-peptic diseases.
Falk GW
Cleve Clin J Med; 1991; 58(5):418-27. PubMed ID: 1934456
[TBL] [Abstract][Full Text] [Related]
40. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
